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Objectives: In patients having mitral valve surgery, concomitant surgery for mild functional tricuspid regurgi-
tation remains the subject of debate. This study examined the effect of Maze operation and tricuspid valve repair
on postoperative functional tricuspid regurgitation progression.
Methods: The study retrospectively analyzed 250 patients (86 men, 164 women) with mild functional tricuspid
regurgitation (grade 2) who had mitral valve surgery between January 1994 and July 2006. Based on follow-up
data, patients were defined as either stable (n ¼ 209, 83.6%) or aggravated (n ¼ 41, 16.4%). Predictors for
significant tricuspid regurgitation development were identified using Cox regression analysis.
Results: The mean follow-up time was 62.6 39.8 months after surgery. Although most mitral valve procedures
were successful, there was an increase in the incidence of significant functional tricuspid regurgitation overall
from immediately postoperative to final assessment (5.2% to 16.4%, P< 0.01). Univariate analysis showed
that old age, shorter aortic crossclamping time, and omission of Maze operation were associated with functional
tricuspid regurgitation progression. Multivariate analysis showed that older age (adjusted hazard ratio, 1.05; 95%
confidence interval, 1.02 to 1.08), a rheumatic etiology of the mitral valve disease (adjusted hazard ratio, 2.31;
95% confidence interval, 1.21 to 4.42), and no Maze operation (adjusted hazard ratio, 7.90; 95% confidence
interval, 1.90 to 32.86) were independent predictors of mild functional tricuspid regurgitation progression. For
the 168 patients with preoperative atrial fibrillation, Maze operation improved the tricuspid regurgitation–free
survival significantly (P< .01) but tricuspid valve repair showed no significant difference.
Conclusions:Mild functional tricuspid regurgitation can progress postoperatively despite successful mitral valve
surgery. Although tricuspid valve repairs alleviate progression of functional tricuspid regurgitation, concomitant
Maze operation is a more powerful protective factor against mild functional tricuspid regurgitation progression.Mitral valvular disease often causes functional tricuspid re-
gurgitation (FTR), which is associated with right ventricular
failure and pulmonary hypertension. Some reports suggest
that tricuspid regurgitation (TR) can be improved after suc-
cessful mitral valve (MV) surgery1 or percutaneous mitral
valvuloplasty.2 However, other reports recommend that
significant FTR should be repaired due to increased postop-
erative morbidity and mortality after left-sided valvular
surgery.3,4
The fate, risk factors, and surgical indications for FTR af-
ter mitral and/or aortic valve surgery have been reported.5-8
Moderate to severe FTR is generally corrected during MV
surgery as significant FTR can increase mortality and mor-
bidity. However, for the mild FTR, the decision to perform
surgery remains debatable in terms of when and how to treat
the tricuspid valve (TV). Although it is not uncommon to
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tively few clinical studies provide information that might
assist in managing this situation. To our knowledge, no stud-
ies have investigated surgical outcomes in patients with mild
FTR exclusively.
Several surgical options for FTR-associated MV disease
have been reported, including MV surgery,1 which expects
to improve FTR as the result of its performance, aggressive
TV repair to prevent TR progression even when the initial
TR was mild,6 and MV surgery with a Maze operation
(MAZE) to prevent progression of functional TR.9 We
hypothesize that concomitant MAZE and TV repair can
prevent progression of mild FTR in patients having MV
surgery.
The present study analyzed surgical outcomes in patients
with mild FTR having MV surgery. The study examined the
effect of MAZE and TV repair on postoperative TR progres-
sion. The study also sought to identify factors associated
with TR progression that may act as indicators for concom-




From January 1994 to July 2006, 2417 patients had MV surgery at the
Asan Medical Center, Seoul, South Korea. Of those, excluded fromardiovascular Surgery c Volume 136, Number 5 1187




ACC ¼ aortic crossclamping
AF ¼ atrial fibrillation
FTR ¼ functional tricuspid regurgitation
MAZE ¼ Maze operation
MR ¼ mitral regurgitation
MV ¼ mitral valve
TAP ¼ tricuspid annuloplasty
TR ¼ tricuspid regurgitation
TV ¼ tricuspid valve
consideration for this study were 1037 patients who had combined surgery
(such as coronary bypass, aortic valve surgery, or thoracic aorta surgery)
and patients who were followed for less than 12 months. Of the remaining
1380 patients who had onlyMV surgery andwere followed for 12months or
more at Asan Medical Center, 250 consecutive patients showing mild FTR
according to preoperative echocardiography were recruited for the study.
Data regarding surgery were prospectively collected, and a thorough echo-
cardiographic follow-up was performed by a cardiologist from our institute.
This study was approved by our institution’s ethical committee/institutional
review board. The informed consent was waived by our institution’s ethical
committee/institutional review board owing to the retrospective nature of
our study.
Echocardiographic Evaluation
Transthoracic echocardiographic evaluation was performed before and
after surgery, and then annually during follow-up. Two-dimensional echo-
cardiography and Doppler color flow imaging were performed on all pa-
tients using a Hewlett-Packard Sonos 2500 or 5500 imaging system
equipped with a 2.5-MHz transducer (Hewlett-Packard, Andover, Mass).
Preoperative transesophageal echocardiography was routinely performed
to evaluate MV morphology.
TR was evaluated using the apical 4-chamber view. TR was graded as
trace, mild, moderate, or severe when the jet area occupied<10%, 10%
to 20%, 20% to 33%, or>33% of the right atrial area, respectively. During
the follow-up, development of moderate to severe TR was defined as signif-
icant TR and was also termed ‘‘aggravated FTR.’’ Postoperative improve-
ment or maintenance of preoperative mild FTR was defined as ‘‘stable
FTR.’’ Based on these definitions, there were 209 (83.6%) patients with sta-
ble FTR and 41 (16.4%) patients with aggravated FTR. Right ventricular
systolic pressures were estimated using continuous-wave Doppler data
and the simplified Bernoulli equation (4 3 [peak TR velocity]2) with 10
mmHg added for the estimated right atrial pressure.10 Residual mitral regur-
gitation (MR) was defined as more than mild MR at follow-up echocardiog-
raphy, and residual MS was defined as less than 1.5 cm2 of the MV area
during follow-up.
Surgical Procedures
All patients had MV surgery without aortic valve or coronary surgery.
MV replacement was performed in 147 patients (58.8%) and MV repair
in 103 (41.2%) patients. MV replacement involved bileaflet mechanical
prostheses (n ¼ 127, 86.4%) or bioprostheses (n ¼ 20, 13.6%). MV repair
was attempted whenever MV pathology was favorable, and MV replace-
ment was performed only when the MV was severely destructed or MV
repair was unsatisfactory on intraoperative transesophageal echocardiogra-
phy. A median sternotomy approach was used for most patients (225, 90%)
and a right anterolateral minithoracotomy approach using the AESOP 3000
system (Computer Motion, Inc., Santa Barbara, CA) was used in the most1188 The Journal of Thoracic and Cardiovascular Surecent 25 (10%) patients. The recent minimally invasive approach has sev-
eral advantages such as stable thoracoscopic view, easily controlled with
surgeon’s voice, and reduction of one surgical assistant. Conventional
ascending aorta and bicaval cannulation was used for the sternotomy
approach, and the minimally invasive approach involved peripheral cannu-
lation via the right internal jugular vein, right femoral vein, and right
femoral artery.
TV repair was performed in 82 (32.8%) patients. Of those, 55 (22.0%)
had suture annuloplasty and 27 (10.8%) had ring annuloplasty. The
decision to perform a TV repair and the choice of repair technique was
at the attending surgeon’s discretion; ring annuloplasty was generally
used for more severe tricuspid annular dilatation. Ring annuloplasty in-
volved a Carpentier ring (Edwards Lifesciences, Irvine, Calif) in 4 patients
and a Duran ring (Medtronic, Minneapolis, Minn) in 23 patients, and the
most common ring size was 27 mm. Kay annuloplasty (bicuspidalization)
or a De Vega procedure (from the anteroseptal to the posteroseptal
commissure) was performed for suture annuloplasty according to surgeon
preference.
Concomitant procedures consisted of MAZE in 73 (29.2%) patients,
atrial septal defect repair in 7 patients, and left atrial myxoma resection in
2 patients. Five patients had a history of percutaneous mitral valvuloplasty.
Among 73MAZEprocedures, between 1997 and 1998, 2 patients had a clas-
sic cut-and-sew Cox-Maze III, and since 1998, 71 patients had simplified
MAZE, which was modified by the authors.11
As MAZE has been performed since 1997 and its application was totally
at the surgeon’s discretion, only a small number of patients had the MAZE
in this study. Recently, the MAZE was rather generally performed to treat
atrial fibrillation (AF) in our institution; however, some authors in this study
have been prudent to perform a MAZE especially in conjunction with MV
replacement using a mechanical prosthesis.
Thirty-eight (15.2%) patients had previous cardiac surgery.
Clinical Follow-up
Clinical follow-up ranged from 12 to 160 months. Data were obtained
during visits to the outpatient clinic or by telephone interview. Patient clin-
ical status and echocardiographic results were obtained from cardiologists at
our institute. Patients had an echocardiography assessment during the week
after surgery, at postoperative 6 months, and then annually during follow-
up. Because patients who had echocardiographic follow-up at local clinics
were excluded from the study design, a complete echocardiogram follow-up
could be achieved in these study populations. Normal sinus rhythm restora-
tion after MAZE was defined as a presence of transmitral A-wave at the last
echocardiographic follow-up.
Statistical Analysis
Continuous variables are presented as mean  standard deviation, and
categorical variables as percentages or numbers. For univariate analyses,
preoperative and operative variables were analyzed using the Kaplan-
Meier method or the Cox regression model to investigate the influence
of these variables on FTR progression during follow-up. The difference
of significant TR development at the immediate postoperative period, at
postoperative 1 year, and the most recent follow-up was assessed using
McNemar’s test. Independent predictors were determined using Cox’s
multivariable analysis involving a backward elimination procedure. The
proportional hazards assumption was confirmed by examination of log
(log [survival]) curves and by testing partial (Schoenfeld) residuals,12
and no relevant violations were found. All P values were 2-sided. Statisti-
cal analysis was performed using SPSS version 12.0 for Windows (SPSS
Inc, Chicago, Ill).
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The patient baseline preoperative and operative character-
istics are summarized in Table 1. There were no significant
differences between the stable and aggravated groups in
terms of left ventricular ejection fraction, left atrial size, esti-
mated systolic pulmonary artery pressure, cardiopulmonary
bypass time, incidence of AF, rheumatic etiology of MV,
or incidence of mitral stenosis. Patients in the aggravated
group were older, more likely to be female, had longer aortic
crossclamping (ACC) time, and were less likely to have had
a MAZE than the stable group. The longer ACC time in the
stable group reflects that the patients were more likely to
have had MV repair, MAZE, and TV repair (Table 1).
Operative Mortality and Morbidities
The operative mortality of all consecutive patients who
hadMV surgery including concomitant surgery during study
period was 2.1% (50/2417).
Among the 250 patients who enrolled in this study, 9 pa-
tients (3.6%) had reoperation for bleeding, 5 patients
TABLE 1. Preoperative and operative characteristics for patients











Age (y) 50.0  13.1 48.9  13.2 55.8  10.6 <.01*
Female 65.6% (164) 60.8% (127) 90.2% (37) <.01y
Atrial fibrillation 67.2% (168) 64.6% (135) 80.5% (33) .13y
Rheumatic etiology 49.6% (124) 47.8% (100) 58.5% (24) .12**
EF (%) 58.1  9.4 58.0  9.6 58.3  8.3 >0.1*
LA size (mm) 59.4  10.9 59.2  11.2 60.6  9.0 >0.1*
sPAP (mm Hg) 49.2  17.8 49.5  17.4 47.7  20.0 >0.1*
MV pathology .12y
Mitral stenosis 44.0% (110) 41.1% (86) 58.5% (24)
Mitral
regurgitation
56.0% (140) 58.9% (123) 41.5% (17)
Operative
CPB time (min) 128.9  47.7 130.9  48.3 118.3  43.6 .14*
ACC time (min) 84.0  35.4 86.6  26.6 70.9  26.6 .02*
MV procedure 0.07y
MV repair 41.2% (103) 44.0% (92) 26.8% (11)
MV replacement 58.8% (147) 56.0% (117) 73.2% (30)
Maze procedure 29.2% (73) 34.0% (71) 4.9% (2) .01y
TV repair 32.8% (82) 35.4% (74) 19.5% (8) .07y
Suture
annuloplasty
22% (55) 23.4% (49) 14.6% (6) NSy
Ring
annuloplasty
10.8% (27) 12.0% (25) 4.9% (2) NSy
Follow-up (months) 62.6  39.8 58.8  38.4 82.3  41.2 .01z
n, Number; CPB, cardiopulmonary bypass; ACC, aortic crossclamp; EF, ejection frac-
tion; LA, left atrium; sPAP, systolic pulmonary artery pressure; MV, mitral valve; TV,
tricuspid valve; NS, not significant. *Cox regression test. yLog-rank test and Kaplan-
Meier analysis. zMann-Whitney test.The Journal of Thoracic and C(2.0%) had minor sternal wound problems, and 3 patients
(1.2%) needed pericardial drainage for severe pericardial ef-
fusion. A permanent pacemaker was inserted in 2.7% (2/73)
of patientswho showed sick sinus syndrome after theMAZE.
Reoperations and Long-Term Clinical Outcomes
The mean follow-up time was 62.6  39.8 months (range
12.0 to 160.3). During the follow-up period, only 3 reopera-
tions were required, and these involved correction for
severely aggravated TR. The incidences of residual mitral
regurgitation and residual mitral stenosis were similar be-
tween the stable and aggravated groups (Table 2). Although
9 of the 13 patients with residual MR had moderate MR and
4 of them had severe MR, all patients responded well to
medical treatment. Two residual MR cases and 3 residual
MS cases were the result of structural deterioration of a bio-
prosthesis. Only 1 reoperation for an MV was required, and
this was in a patient who had mitral annuloplasty with a Du-
ran ring. That patient had a reoperation for severe MS with
severe TR at 82 months after the initial operation. Compared
with the stable group, the aggravated group had a lower left
ventricular ejection fraction, bigger left atrium size, higher
systolic pulmonary artery pressure, and greater prevalence
of atrial fibrillation on the most recent echocardiographic
examination (Table 2).
Although only 5.2% (13/250) of patients showed signif-
icant TR according to immediate postoperative echocardiog-
raphy, 16.4% (41/250) of patients showed significant TR
at the final follow-up (Figure 1), which was a significantly
greater figure.
Although MAZE had a significant effect on freedom from
significant TR development during follow-up, the effect of
tricuspid annuloplasty (TAP) showed marginal significance
(Figure 2).
As an application of MAZE and TV repair was totally at
the surgeon’s discretion, the possibility of preoperative
selection bias was concerned. However, the preoperative
variables such as age, left ventricular ejection fraction, and
systolic pulmonary pressure were not significantly different
between groups.









Residual MR 5.2% (13) 4.8% (10) 7.3% (3) >0.1
Residual MS 2.4% (6) 1.9% (4) 4.9% (2) >0.1
Last EF (%) 57.6  8.1 58.1  7.5 55.1  10.1 .03
Last LA size (mm) 49.7  9.3 48.6  9.1 55.2  8.4 <.01
Last sPAP (mm Hg) 36.2  7.5 35.0  6.3 41.5  9.8 <.01
Last NSR 61.2% (153) 70.8% (148) 12.2% (5) <.01
Last Af, Afl, PPM 38.8% (97) 29.2% (61) 87.8% (36) <.01
n, Number;MR,mitral regurgitation;MS,mitral stenosis;EF, ejection fraction; LA, left
atrium; sPAP, systolic pulmonary artery pressure; NSR, normal sinus rhythm; Af, atrial
fibrillation; Afl, atrial flutter; PPM, permanent pacemaker; NS, not significant.ardiovascular Surgery c Volume 136, Number 5 1189
Surgery for Acquired Cardiovascular Disease Je et al
A
C
DRisk Factor Analysis of Late Significant TR
The crude relative risks of FTR progression in terms of
preoperative and operative variables are shown in Table 3.
Univariate analysis showed FTR progression was associated
with elderly patients, shorter ACC time, and omission of
MAZE. The effect of preoperative atrial fibrillation, MV re-
placement (compared with repair), and no TV repair ap-
proached but did not quite reach significance in univariate
FIGURE 1. Significant tricuspid regurgitation development over time. A,
Immediate postoperative evaluation; B, evaluation at postoperative 1 year;
C, evaluation at the last follow-up. *P> .1 versus A; yP< .01 versus A;
zP< .01 versus B.1190 The Journal of Thoracic and Cardiovascular Sanalysis (Table 3). Multivariate analysis showed that older
age, a rheumatic etiology of the MV disease, and no
MAZE were independent predictors of FTR aggravation
after successful MV surgery (Table 3).
Effect of MAZE and TV repair in the AF group
The protective effects of MAZE and TAP were further
evaluated in the 168 patients with preoperative atrial fibrilla-
tion. Of those, 75 had MV surgery without TAP or MAZE,
and the other 93 patients concomitantly had TAP (n ¼ 20),
MAZE (n¼ 33), or TAP with MAZE (n¼ 40). It was found
that 36% (27/75), 20% (4/20), 3.0% (1/33), and 2.5% (1/
40) of those patients developed significant TR during fol-
low-up, respectively, and the difference of FTR progression
following concomitant surgery is shown in Figure 3. Only 2
patients had significant TR following MAZE; an atrial fibril-
lation recurrence in 1 patient and a maintained sinus rhythm
without right atrium (RA) mechanical activity in the other.
Among the 73 patients who had MAZE, the normal sinus
rhythm restoration rate was 87.7% (64/73) at 47.2  26.8
months follow-up, 7 patients had recurring AF, and 2 pa-
tients maintained pacing rhythm. Most of the 64 patients
who had restored normal sinus rhythm after MAZE were
well maintained without antiarrhythmic medication; how-
ever, only 6.3% (4/64) and 3.1% (2/64) of patients required
antiarrhythmic drugs a year after MAZE and the last follow-
up, respectively.
DISCUSSION
Surgical treatment of mild FTR with concomitant MV
disease remains a topic of debate. Although intraoperative
inspection and palpation of the TV are frequently used toFIGURE 2. Kaplan-Meier analysis of long-term freedom from significant tricuspid regurgitation in (A) patients having Maze procedure (MAZE) versus
patients not having Maze procedure (non-MAZE), and (B) patients having tricuspid annuloplasty (TAP) versus patients not having tricuspid annuloplasty
(non-TAP.)urgery c November 2008
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Devaluate the necessity of tricuspid repair, such methods can
be subjective and may lead to incorrect management deci-
sions. Recently suggested indicators for TV repair include
the tricuspid annular diameter and the tricuspid annular
function.8,12 However, preoperative assessment of the tri-
cuspid annular diameter and function using echocardiogra-
phy is unreliable and difficult as it can depend on the
preload and afterload of the right ventricle at the time of
measurement, and precise measurement of the tricuspid an-
nulus is difficult and irreproducible due to the 3-dimensional
structure of the TV.
Several reports suggest that TR can be regressive after
successful mitral balloon valvuloplasty or surgery. It appears
logical that significant FTR could be resolved if the transmi-
tral pressure gradient and pulmonary artery pressure were
markedly lowered.2 This concept is supported by findings
that minimal right atrium (RA) enlargement andþ1 toþ2 re-
gurgitation usually resolves after surgery on left-sided valve
lesions, especially if the pulmonary hypertension resolves.13
In contrast, other studies reported that FTR could be progres-
sive and should be treated even if preoperative TR is mild or
grade II.6,14 In the present study, although only 5.2% of pa-
tients showed significant TR at the immediate postoperative
echocardiography assessment, this number increased to
16.4% at the final follow-up. This finding suggests that
TR can be progressive despite MV pathology being relieved.
Although some studies conclude ring annuloplasty is
superior to suture annuloplasty for TR repair,15 others recom-
mend ring annuloplasty for severe TR and suture annulo-
plasty for mild to moderate TR.14 In the present study,
patients having ring annuloplasty and patients having suture
TABLE 3. Univariate and multivariate Cox regression analysis to
identify factors associated with mild functional tricuspid valve
regurgitation progression after mitral valve surgery
CRR P value AHR P value 95% CI
Age (years) 1.044 <.01 1.05 <.01 1.02–1.08
Atrial fibrillation 1.812 0.13
Rheumatic etiology 1.624 .13 2.31 .01 1.21–4.42
Preop EF (%) 1.002 >0.1
Preop LA size (mm) 1.010 >0.1
Preop sPAP (mm Hg) 1.004 >0.1
MV pathology 1.640 .12
Mitral stenosis
Mitral regurgitation
CPB time (min) 0.995 .14
ACC time (min) 0.989 .02
MV procedure 1.88 .07
MV repair
MV replacement
No MAZE 7.11 <.01 7.90 <.01 1.90–32.86
TV repair 0.49 0.07
n, Number; CRR, crude relative risk; AHR, adjusted hazard ratio; CI, confidence inter-
val; EF, ejection fraction; LA, left atrium; Preop, preoperative; sPAP, systolic pulmo-
nary artery pressure; MV, mitral valve; CPB, cardiopulmonary bypass; ACC, aortic
crossclamp; TV, tricuspid valve; NS, not significant.The Journal of Thoracic and Cannuloplasty showed similar postoperative significant TR
development rates. This may reflect that the present study
population was exclusively patients with mild FTR and
contained a small number of patients who had TR repair.
Previous studies identified several clinical and echocar-
diographic factors associated with development of late TR
after left-sided valve surgery, such as atrial fibrillation, rheu-
matic etiology, older age, lower left ventricular ejection frac-
tion, huge left atrium, and higher preoperative TR grade.6,16
Most risk factors for late FTR development are related to the
chronic course of the left-sided valvular disease, and these
chronic changes may contribute to irreversible changes to
the tricuspid annulus and right ventricular function. The
findings of the present study indicate that older age and
a rheumatic etiology of the MV are strong predictors of sig-
nificant TR progression after MV surgery even when the
FTR is mild.
Because atrial fibrillation is a well-known risk factor for
TR aggravation,6,9 a recent study suggested that sinus con-
version resulting from MAZE can prevent FTR progres-
sion.9 In the present study, MAZE was found to be the
most important predictor of FTR aggravation after MV sur-
gery, and the incidence of significant TR progression by
omission of MAZE increased 7.9 times. Although TV repair
might alleviate mild FTR progression in patients with atrial
fibrillation, MAZE had a more potent protective effect.
FIGURE 3. The effect of tricuspid annuloplasty and the Maze procedure
on significant tricuspid regurgitation (TR)-free survival rates in patients
with atrial fibrillation. B, no tricuspid annuloplasty or Maze procedure;
C, tricuspid annuloplasty only; ,, Maze procedure only; 6, tricuspid
annuloplasty and Maze procedure.ardiovascular Surgery c Volume 136, Number 5 1191




First, this study was subject to the limitations inherent to
a nonrandomized, retrospective, observational data study of
relatively small number of patients. Second, the present
study contained several inherent selection biases because
the decision to perform MAZE and/or tricuspid valvulo-
plasty was wholly dependent on surgeon preference. Third,
ideally more precise data concerning MAZE should have
been collected. Further studies are required to determine
the relationship between FTR progression and restoration
of sinus rhythm and/or effective atria contraction after
MAZE in a larger study group. Fourth, precise assessments
of the tricuspid annulus and right ventricular function were
not conducted, thus sophisticated variables such as TV teth-
ering distance and TV tethering area could not be estimated.
CONCLUSIONS
Mild FTR was shown to progress despite successful MV
surgery. Older age and a rheumatic etiology of the MV
disease were shown to be independent predictors of FTR
progression. Although TV repair may protect against FTR
progression, having MAZE was found to be a more impor-
tant predictor of TR progression. From the present findings,
we believe that MAZE should be performed not only for
sinus restoration and alleviation of embolic complication
after MV surgery but also for protecting against aggravation
of mild FTR over the long term.
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